The N-terminal copper-binding domain of the amyloid precursor protein protects against Cu<SUP>2+</SUP> neurotoxicity in vivo
dc.contributor.author | Cerpa, WF | |
dc.contributor.author | Barría, MI | |
dc.contributor.author | Chacón, MA | |
dc.contributor.author | Suazo, M | |
dc.contributor.author | González, M | |
dc.contributor.author | Opazo, C | |
dc.contributor.author | Bush, AI | |
dc.contributor.author | Inestrosa, NC | |
dc.date.accessioned | 2025-01-21T01:07:40Z | |
dc.date.available | 2025-01-21T01:07:40Z | |
dc.date.issued | 2004 | |
dc.description.abstract | The amyloid precursor protein (APP) contains a Cu binding domain (CuBD) localized between amino acids 135 and 156 (APP(135-156)), which can reduce Cu2+ to Cu1+ in vitro. The physiological function of this APP domain has not yet being established; nevertheless several studies support the notion that the CuBD of APP is involved in Cu homeostasis. We used APP synthetic peptides to evaluate their protective properties against Cu2+ neurotoxicity in a bilateral intra-hippocampal injection model. We found that human APP135-156 protects against Cu2+-induced neurotoxic effects, such as, impairment of spatial memory, neuronal cell loss, and astrogliosis. APP135-156 lacking two histidine residues showed protection against Cu2+; however, APP135-156 mutated in cysteine 144, a key residue in the reduction of Cu2+ to Cu1+, did not protect against Cu2+ neurotoxicity. In accordance with recent reports, the CuBD of the Caenorhabditis elegans, APL-1 protected against Cu2+ neurotoxicity in vivo. We also found that Cu2+ neurotoxicity is associated with an increase in nitrotyrosine immunofluorescence as well as with a decrease in Cu2+ uptake. The CuBD of APP therefore may play a role in the detoxification of brain Cu. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1096/fj.03-1349fje | |
dc.identifier.eissn | 1530-6860 | |
dc.identifier.issn | 0892-6638 | |
dc.identifier.uri | https://doi.org/10.1096/fj.03-1349fje | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/96363 | |
dc.identifier.wosid | WOS:000224243200045 | |
dc.issue.numero | 12 | |
dc.language.iso | en | |
dc.pagina.final | + | |
dc.pagina.inicio | 1701 | |
dc.revista | Faseb journal | |
dc.rights | acceso restringido | |
dc.subject | water maze | |
dc.subject | intracerebral injection | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | The N-terminal copper-binding domain of the amyloid precursor protein protects against Cu<SUP>2+</SUP> neurotoxicity in vivo | |
dc.type | artículo | |
dc.volumen | 18 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |